Eli Lilly boosts China footprint with US$3 billion plan to expand supply chain

Eli Lilly has pledged an additional US$3 billion investment in China over the next decade to strengthen its local supply chain and manufacturing capabilities, deepening the footprint of foreign pharmaceutical giants in the world’s second-largest healthcare market. The move would bring the total cumulative investment of Eli Lilly, the world’s largest pharmaceutical company by market capitalisation, in China to nearly US$6 billion, according to a statement released on its WeChat account on...


3 h.
Economics
ID: -1909462954904436947


Similar News expand_more


Economics
Economics
Economics
Technology
Economics
Technology
Economics
Economics
Economics
Economics
Economics
Economics
Economics
Technology
Technology
Economics
Economics
Economics
Economics
Economics
Economics
Economics
Economics
Economics
Economics
Technology
Economics
Economics
Technology
Technology
Economics
Economics
Economics
Economics
Technology
Economics
Economics
Economics
Economics
Technology
Economics
Economics
Technology
Economics
Economics
Economics
Economics
Technology
Economics
Popular countries based on strong economic and political relations

Add Watch Country

arrow_drop_down